Go to deals
Healthcare

Thubilux Pharma SpA has received a structured loan of US$2.7 million from a leading Italian bank

Tubilux Pharma SpA has successfully raised funds through a structured loan from Cassa Depositi e Prestiti SpA and Banca Intesa San Paolo SpA to support an investment plan for a new production facility which has all the FDA requirements to enter the USA market.

Tubilux Pharma is a leading, privately-held ophthalmic and pharmaceuticals company that develops and markets a range of proprietary, over-the-counter, and branded generic products, with distribution in approximately 30 countries. The firm's customers are large multinational pharmaceutical companies that outsource their production of ophthalmic products to specialized manufactures through medium-term supply contracts (3-5 years).

Oaklins' team in Italy advised Thubilux Pharma SpA in the structuring, negotiation and closing of a long-term debt financing from a leading Italian bank, backed by Cassa Depositi e Prestiti.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Federico  Cappa

Federico Cappa

Partner

Milan, Italy
Oaklins Italy
 Marie Gabriella  Sestini

Marie Gabriella Sestini

Associate

Milan, Italy
Oaklins Italy

Related deals

Navitas Petroleum has issued bonds
Energy

Navitas Petroleum has issued bonds

Navitas Petroleum has completed a fundraising to refinance and develop the business.

Learn more
Solstyce has completed an LBO alongside NextStage
Private Equity | Construction & Engineering Services | Energy

Solstyce has completed an LBO alongside NextStage

The private shareholders of Solstyce have completed a primary LBO alongside NextStage AM.

Learn more
DIMOTRANS has raised debt to acquire Crystal Group
Logistics

DIMOTRANS has raised debt to acquire Crystal Group

DIMOTRANS has raised debt with a pool of banks led by CIC Lyonnaise de Banque.

Learn more